Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-029093

Options or other derivatives

  • Chief Financial Officer acquired 168,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-02 Grant or award : show line 1 in the form Stock Option (right to buy) +168,750 168,750 D
Loading xslF345X03/tm238642-1_4seq1.xml…